Ad
related to: pfizer news
Search results
Results from the WOW.Com Content Network
The analyst anticipates that Pfizer’s management will guide to EPS in the mid-to-high $2 range with core business growth offset by the $0.30 in favorable but non-recurring items during 2024.
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.
Pfizer raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen and strong sales of its heart disease drug as the company deals with ...
Pfizer's shares were up 2.6% at $29.30 in afternoon trading. Pfizer made the disclosure on Wednesday in a filing with the Securities and Exchange Commission. Pfizer rolls out another cost-cutting ...
The Seagen deal, as well as its $4 billion cost-cutting plan, are a key part of Pfizer's post-COVID growth stra Pfizer lifts profit forecast as CEO sees reason for optimism in 2024 Skip to main ...
Pfizer said Tuesday that it now expects adjusted earnings to range between $2.75 and $2.95 per share for 2024. That amounts to a 30 cent increase at the midpoint from a forecast the company made ...
Pfizer on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, a move top executives said provided a more reliable view of its COVID-19 business than ...
The company on Wednesday forecast revenue from its COVID-19 vaccine and treatment to be $8 billion in 2024, a far cry from the $57 billion in 2022. In March, Pfizer announced a $43 billion ...
Ad
related to: pfizer news